TG
GILD icon

TLP Group’s Gilead Sciences GILD Stock Holding History

TLP Group’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-20,000
Closed -$12K – 179
2018
Q3 		$12K Hold
20,000
– – 0.02% 367
2018
Q2 		$58K Hold
20,000
– – 0.09% 158
2018
Q1 		$98K Hold
20,000
– – 0.07% 306
2017
Q4 		$126K Hold
20,000
– – 0.09% 180
2017
Q3 		$104K Buy
+20,000
New +$1.53M 0.07% 224

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

TLP Group's GILD Position: Q4 2018 in Review

TLP Group sold out of Gilead Sciences (GILD) in Q4 2018, closing a stake of 3,295 shares — an estimated $254K sold.

TLP Group first reported a position in GILD in Q4 2015 and held it in 7 quarters. The position peaked at $380K in Q1 2017. 1,496 funds tracked by Wall St. Rank hold GILD as of Q4 2018.

  • TLP Group reported no remaining Gilead Sciences position as of Q4 2018 after selling out during the quarter.
  • TLP Group sold 3,295 Gilead Sciences shares in Q4 2018, an estimated $254K.
  • TLP Group first reported a position in Gilead Sciences in Q4 2015 and held it in 7 quarters.
  • TLP Group's Gilead Sciences position peaked at $380K in Q1 2017.
  • 1,496 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2018.

Based on TLP Group's 13F filing for Q4 2018, filed 14 Feb 2019.